On Thursday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $115.3 which represents a decrease of $-1.50 or -1.28% from the prior close of $116.8. The stock opened at $117.49 and ...

Shares of Abbott Laboratories ABT slumped 0.79% to $116.80 Wednesday, on what proved to be an all-around great trading ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

Following the robust Q3 performance, Piper Sandler raised ABT’s price target to $133 from $131, keeping an Overweight rating ...

Reckitt shares surged more than 10% in London following the news, and Abbott stock added 5% in US premarket trading. "The ...

The adjustment follows a favorable verdict for Abbott in a recent NEC lawsuit in St. Louis. The analyst from Barclays indicated that despite the stock's recent gains, including an 18% rise from ...

On Tuesday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.73 which represents a slight increase of $0.08 or 0.07% from the prior close of $117.65. The stock opened at ...

In the last year, many Abbott Laboratories (NYSE ... However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...